Table 2.
Demographic data and pre-existing neurological and non-neurological conditions.
| Total (n = 82) | Hospitalised (n = 40) | Outpatient (n = 42) |
|||
|---|---|---|---|---|---|
| Onset (day) | Duration (days) | ||||
| Neurological symptoms | 68 (83%) | 32 (80%) | 36 (86%) | 1.6 ± 2.4 | 28.5 ± 29.2 |
| Neurological symptoms | |||||
| Fatigue | 44 (54%) | 21 (53%) | 23 (55%) | 2.5 ± 3.0 | 11.0 ± 16.7 |
| Headache | 25 (31%) | 13 (33%) | 12 (29%) | 1.0 ± 2.2 | 3.2 ± 1.3 |
| Loss of taste | 25 (31%) | 4 (10%) | 21 (50%) | 4.5 ± 3.2 | 21.6 ± 28.5 |
| Loss of smell | 22 (27%) | 3 (8%) | 19 (45%) | 5.5 ± 4.4 | 28.5 ± 30.7 |
| Vertigo | 13 (16%) | 6 (15%) | 7 (17%) | 2.6 ± 2.4 | 15.9 ± 33.2 |
| Mood disturbance | 13 (16%) | 8 (20%) | 5 (12%) | 24.1 ± 25.9 | 16.2 ± 11.4 |
| Hallucinations/confusion | 9 (11%) | 9 (23%) | 0 (0%) | ||
| Back pain | 8 (10%) | 4 (10%) | 4 (10%) | 0.8 ± 1.5 | 8.5 ± 3.8 |
| Sensory symptoms | 5 (6%) | 1 (3%) | 4 (10%) | 26.4 ± 16.3 | 22.2 ± 20.9 |
| Myalgia | 5 (6%) | 2 (5%) | 3 (7%) | 2.7 ± 3.8 | 17.0 ± 6.1 |
| Mononeuropathy | 3 (4%) | 0 (0%) | 3 (7%) | 26.7 ± 16.5 | 33.7 ± 7.4 |
| Reduced alertness | 3 (4%) | 3 (8%) | 0 (0%) | ||
| Unsteadiness | 2 (2%) | 2 (5%) | 0 (0%) | ||
| Epileptic seizure | 1 (1%) | 1 (3%) | 0 (0%) | ||
| Dysphagia | 1 (1%) | 1 (3%) | 0 (0%) | ||